Our study recently published in Clinical Cancer Research shows that combining drugs that target a variety of developmental cell signaling pathways may do a better job of killing deadly brain tumors than single drugs that target one pathway at a time. The combined therapy approach reduces tumor resistance to anti-Notch chemotherapy.The link to a press release describing this work is below.